ID   NKTR_HUMAN              Reviewed;        1462 AA.
AC   P30414;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   15-MAR-2017, entry version 146.
DE   RecName: Full=NK-tumor recognition protein;
DE            Short=NK-TR protein;
DE   AltName: Full=Natural-killer cells cyclophilin-related protein;
DE   Includes:
DE     RecName: Full=Putative peptidyl-prolyl cis-trans isomerase;
DE              Short=PPIase;
DE              EC=5.2.1.8;
DE     AltName: Full=Rotamase;
GN   Name=NKTR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=8421688; DOI=10.1073/pnas.90.2.542;
RA   Anderson S.K., Gallinger S., Roder J., Frey J., Young H.A.,
RA   Ortaldo J.R.;
RT   "A cyclophilin-related protein involved in the function of natural
RT   killer cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:542-546(1993).
RN   [2]
RP   SEQUENCE REVISION.
RA   Anderson S.K.;
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Anderson S.K.;
RT   "Structure of the human NKTR gene.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-463; SER-887; SER-889
RP   AND SER-891, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-463 AND SER-1146, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-463; SER-1146
RP   AND THR-1155, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-401; SER-416; SER-463;
RP   SER-471; SER-648; SER-866; SER-889; SER-1077; SER-1146; THR-1155 AND
RP   SER-1203, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1155, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-323; LYS-581; LYS-1057 AND
RP   LYS-1258, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-581 AND LYS-1177, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-323; LYS-1057 AND LYS-1258,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-323; LYS-581 AND LYS-666,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
CC   -!- FUNCTION: Component of a putative tumor-recognition complex.
CC       Involved in the function of NK cells.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein.
CC       Note=Attached to the membrane via its N-terminus.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L04288; AAA35734.2; -; mRNA.
DR   EMBL; AF184110; AAD56402.1; -; Genomic_DNA.
DR   CCDS; CCDS2702.1; -.
DR   PIR; A47328; A47328.
DR   RefSeq; NP_005376.2; NM_005385.3.
DR   UniGene; Hs.529509; -.
DR   PDB; 2HE9; X-ray; 2.00 A; A/B=7-179.
DR   PDBsum; 2HE9; -.
DR   ProteinModelPortal; P30414; -.
DR   SMR; P30414; -.
DR   BioGrid; 110885; 22.
DR   IntAct; P30414; 7.
DR   STRING; 9606.ENSP00000232978; -.
DR   iPTMnet; P30414; -.
DR   PhosphoSitePlus; P30414; -.
DR   BioMuta; NKTR; -.
DR   DMDM; 8039798; -.
DR   EPD; P30414; -.
DR   MaxQB; P30414; -.
DR   PaxDb; P30414; -.
DR   PeptideAtlas; P30414; -.
DR   PRIDE; P30414; -.
DR   DNASU; 4820; -.
DR   Ensembl; ENST00000232978; ENSP00000232978; ENSG00000114857.
DR   GeneID; 4820; -.
DR   KEGG; hsa:4820; -.
DR   UCSC; uc003clo.4; human.
DR   CTD; 4820; -.
DR   DisGeNET; 4820; -.
DR   GeneCards; NKTR; -.
DR   HGNC; HGNC:7833; NKTR.
DR   HPA; HPA022120; -.
DR   HPA; HPA051576; -.
DR   MIM; 161565; gene.
DR   neXtProt; NX_P30414; -.
DR   OpenTargets; ENSG00000114857; -.
DR   PharmGKB; PA31641; -.
DR   eggNOG; KOG0546; Eukaryota.
DR   eggNOG; COG0652; LUCA.
DR   GeneTree; ENSGT00550000074595; -.
DR   HOGENOM; HOG000113792; -.
DR   HOVERGEN; HBG052631; -.
DR   InParanoid; P30414; -.
DR   KO; K12740; -.
DR   OMA; DRSAYSK; -.
DR   OrthoDB; EOG091G0BGL; -.
DR   PhylomeDB; P30414; -.
DR   TreeFam; TF318563; -.
DR   ChiTaRS; NKTR; human.
DR   EvolutionaryTrace; P30414; -.
DR   GeneWiki; NKTR; -.
DR   GenomeRNAi; 4820; -.
DR   PMAP-CutDB; P30414; -.
DR   PRO; PR:P30414; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114857; -.
DR   CleanEx; HS_NKTR; -.
DR   ExpressionAtlas; P30414; baseline and differential.
DR   Genevisible; P30414; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0016018; F:cyclosporin A binding; TAS:ProtInc.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Isomerase; Isopeptide bond; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Rotamase;
KW   Ubl conjugation.
FT   CHAIN         1   1462       NK-tumor recognition protein.
FT                                /FTId=PRO_0000064217.
FT   DOMAIN       10    175       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   REGION     1311   1348       Arg/Ser tandem repeat-rich.
FT   COMPBIAS    194    244       Arg/Ser-rich.
FT   COMPBIAS    219    240       Arg/Lys-rich (basic).
FT   COMPBIAS    421    457       Arg/Lys-rich (basic).
FT   COMPBIAS    466    574       Arg/Ser-rich.
FT   COMPBIAS    664    814       Arg/Ser-rich.
FT   COMPBIAS    970   1010       Arg/Lys-rich (basic).
FT   MOD_RES     379    379       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     401    401       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     416    416       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     463    463       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     471    471       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     613    613       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P30415}.
FT   MOD_RES     648    648       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     866    866       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     887    887       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     889    889       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     891    891       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     907    907       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P30415}.
FT   MOD_RES    1077   1077       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1146   1146       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1155   1155       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1203   1203       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    323    323       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364}.
FT   CROSSLNK    581    581       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297}.
FT   CROSSLNK    666    666       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297}.
FT   CROSSLNK   1057   1057       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364}.
FT   CROSSLNK   1177   1177       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK   1258   1258       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364}.
FT   VARIANT     271    271       V -> G (in dbSNP:rs35726114).
FT                                /FTId=VAR_061765.
FT   VARIANT     861    861       L -> V (in dbSNP:rs33969824).
FT                                /FTId=VAR_051773.
FT   VARIANT     935    935       S -> L (in dbSNP:rs35770315).
FT                                /FTId=VAR_051774.
FT   VARIANT    1182   1182       M -> T (in dbSNP:rs34897686).
FT                                /FTId=VAR_061766.
FT   STRAND        8     15       {ECO:0000244|PDB:2HE9}.
FT   STRAND       18     27       {ECO:0000244|PDB:2HE9}.
FT   TURN         29     31       {ECO:0000244|PDB:2HE9}.
FT   HELIX        33     44       {ECO:0000244|PDB:2HE9}.
FT   TURN         51     53       {ECO:0000244|PDB:2HE9}.
FT   STRAND       55     57       {ECO:0000244|PDB:2HE9}.
FT   STRAND       63     68       {ECO:0000244|PDB:2HE9}.
FT   TURN         69     71       {ECO:0000244|PDB:2HE9}.
FT   STRAND       72     75       {ECO:0000244|PDB:2HE9}.
FT   TURN         78     80       {ECO:0000244|PDB:2HE9}.
FT   STRAND       81     84       {ECO:0000244|PDB:2HE9}.
FT   STRAND      108    111       {ECO:0000244|PDB:2HE9}.
FT   STRAND      123    128       {ECO:0000244|PDB:2HE9}.
FT   HELIX       131    133       {ECO:0000244|PDB:2HE9}.
FT   TURN        134    136       {ECO:0000244|PDB:2HE9}.
FT   STRAND      139    145       {ECO:0000244|PDB:2HE9}.
FT   HELIX       147    154       {ECO:0000244|PDB:2HE9}.
FT   STRAND      164    166       {ECO:0000244|PDB:2HE9}.
FT   STRAND      168    175       {ECO:0000244|PDB:2HE9}.
SQ   SEQUENCE   1462 AA;  165677 MW;  D98A1147763EF527 CRC64;
     MGAQDRPQCH FDIEINREPV GRIMFQLFSD ICPKTCKNFL CLCSGEKGLG KTTGKKLCYK
     GSTFHRVVKN FMIQGGDFSE GNGKGGESIY GGYFKDENFI LKHDRAFLLS MANRGKHTNG
     SQFFITTKPA PHLDGVHVVF GLVISGFEVI EQIENLKTDA ASRPYADVRV IDCGVLATKS
     IKDVFEKKRK KPTHSEGSDS SSNSSSSSES SSESELEHER SRRRKHKRRP KVKRSKKRRK
     EASSSEEPRN KHAMNPKGHS ERSDTNEKRS VDSSAKREKP VVRPEEIPPV PENRFLLRRD
     MPVVTAEPEP KIPDVAPIVS DQKPSVSKSG RKIKGRGTIR YHTPPRSRSC SESDDDDSSE
     TPPHWKEEMQ RLRAYRPPSG EKWSKGDKLS DPCSSRWDER SLSQRSRSWS YNGYYSDLST
     ARHSGHHKKR RKEKKVKHKK KGKKQKHCRR HKQTKKRRIL IPSDIESSKS STRRMKSSCD
     RERSSRSSSL SSHHSSKRDW SKSDKDVQSS LTHSSRDSYR SKSHSQSYSR GSSRSRTASK
     SSSHSRSRSK SRSSSKSGHR KRASKSPRKT ASQLSENKPV KTEPLRATMA QNENVVVQPV
     VAENIPVIPL SDSPPPSRWK PGQKPWKPSY ERIQEMKAKT THLLPIQSTY SLANIKETGS
     SSSYHKREKN SESDQSTYSK YSDRSSESSP RSRSRSSRSR SYSRSYTRSR SLASSHSRSR
     SPSSRSHSRN KYSDHSQCSR SSSYTSISSD DGRRAKRRLR SSGKKNSVSH KKHSSSSEKT
     LHSKYVKGRD RSSCVRKYSE SRSSLDYSSD SEQSSVQATQ SAQEKEKQGQ MERTHNKQEK
     NRGEEKSKSE RECPHSKKRT LKENLSDHLR NGSKPKRKNY AGSKWDSESN SERDVTKNSK
     NDSHPSSDKE EGEATSDSES EVSEIHIKVK PTTKSSTNTS LPDDNGAWKS SKQRTSTSDS
     EGSCSNSENN RGKPQKHKHG SKENLKREHT KKVKEKLKGK KDKKHKAPKR KQAFHWQPPL
     EFGEEEEEEI DDKQVTQESK EKKVSENNET IKDNILKTEK SSEEDLSGKH DTVTVSSDLD
     QFTKDDSKLS ISPTALNTEE NVACLQNIQH VEESVPNGVE DVLQTDDNME ICTPDRSSPA
     KVEETSPLGN ARLDTPDINI VLKQDMATEH PQAEVVKQES SMSESKVLGE VGKQDSSSAS
     LASAGESTGK KEVAEKSQIN LIDKKWKPLQ GVGNLAAPNA ATSSAVEVKV LTTVPEMKPQ
     GLRIEIKSKN KVRPGSLFDE VRKTARLNRR PRNQESSSDE QTPSRDDDSQ SRSPSRSRSK
     SETKSRHRTR SVSYSHSRSR SRSSTSSYRS RSYSRSRSRG WYSRGRTRSR SSSYRSYKSH
     RTSSRSRSRS SSYDPHSRSR SYTYDSYYSR SRSRSRSQRS DSYHRGRSYN RRSRSCRSYG
     SDSESDRSYS HHRSPSESSR YS
//
